Section Arrow
PLRZ.NASDAQ
- Polyrizon Ltd.
Quotes are at least 15-min delayed:2026/02/20 16:59 EST
After Hours
Last
 13.25
+0.23 (+1.77%)
Bid
13.02
Ask
13.19
High 13.25 
Low 13.02 
Volume
Regular Hours (Closed)
Last
 13.02
-0.61 (-4.48%)
Day High 
14 
Prev. Close
13.63 
1-M High
16.4999 
Volume 
27.84K 
Bid
13.02
Ask
13.19
Day Low
12.44 
Open
14 
1-M Low
11.2425 
Market Cap 
14.20M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 13.45 
20-SMA 13.96 
50-SMA 12.54 
52-W High 2,235 
52-W Low 2.88 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.22/--
Enterprise Value
14.20M
Balance Sheet
Book Value Per Share
17.64
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
CDIOCardio Diagnostics Holdings Inc.2.88+0.64+28.57%-- 
After Hours 2.9046 +0.0246 +0.85%
IBRXImmunityBio8.7+0.09+1.05%-- 
After Hours 8.6902 -0.0098 -0.11%
GERNGeron Corp1.88-0.04-2.08%-- 
After Hours 1.88 0 0.00%
QNCXQuince Therapeutics0.1501-0.0121-7.46%-- 
After Hours 0.1507 +0.0006 +0.40%
RXRXRecursion Pharmaceuticals3.42-0.3-8.06%-- 
After Hours 3.43 +0.01 +0.29%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.